• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Control Hosp Epidemiol. Escalating infection control response to the rapidly evolving epidemiology of the Coronavirus disease 2019 (COVID-19) d

tetano

Editor, Senior Moderator
Infect Control Hosp Epidemiol. 2020 Mar 5:1-24. doi: 10.1017/ice.2020.58. [Epub ahead of print] [h=1]Escalating infection control response to the rapidly evolving epidemiology of the Coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong.[/h]
Cheng VCC[SUP]#[/SUP][SUP]1,[/SUP][SUP]2[/SUP], Wong SC[SUP]#[/SUP][SUP]2[/SUP], Chen JHK[SUP]1[/SUP], Yip CCY[SUP]1[/SUP], Chuang VWM[SUP]3[/SUP], Tsang OTY[SUP]4[/SUP], Sridhar S[SUP]5[/SUP], Chan JFW[SUP]5[/SUP], Ho PL[SUP]5[/SUP], Yuen KY[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] To describe the infection control preparedness for Coronavirus Disease (COVID-19) due to SARS-CoV-2 [previously known as 2019-novel coronavirus] in the first 42 days after announcement of a cluster of pneumonia in China, on 31 December 2019 (day 1) in Hong Kong.
[h=4]METHODS:[/h] A bundle approach of active and enhanced laboratory surveillance, early airborne infection isolation, rapid molecular diagnostic testing, and contact tracing for healthcare workers (HCWs) with unprotected exposure in the hospitals was implemented. Epidemiological characteristics of confirmed cases, environmental and air samples were collected and analyzed.
[h=4]RESULTS:[/h] From day 1 to day 42, forty-two (3.3%) of 1275 patients fulfilling active (n=29) and enhanced laboratory surveillance (n=13) confirmed to have SARS-CoV-2 infection. The number of locally acquired case significantly increased from 1 (7.7%) of 13 [day 22 to day 32] to 27 (93.1%) of 29 confirmed case [day 33 to day 42] (p<0.001). Twenty-eight patients (66.6%) came from 8 family clusters. Eleven (2.7%) of 413 HCWs caring these confirmed cases were found to have unprotected exposure requiring quarantine for 14 days. None of them was infected and nosocomial transmission of SARS-CoV-2 was not observed. Environmental surveillance performed in a patient with viral load of 3.3x106 copies/ml (pooled nasopharyngeal/ throat swab) and 5.9x106 copies/ml (saliva) respectively. SARS-CoV-2 revealed in 1 (7.7%) of 13 environmental samples, but not in 8 air samples collected at a distance of 10 cm from patient's chin with or without wearing a surgical mask.
[h=4]CONCLUSION:[/h] Appropriate hospital infection control measures could prevent nosocomial transmission of SARS-CoV-2.


PMID: 32131908 DOI: 10.1017/ice.2020.58
 
Back
Top